Coronary Artery Disease and Myocardial Infarction

ACC.24: The ORBITA COSMIC Trial

Rasha Al-Lamee, Michael Foley,

Watch time: 4m 45s
ACC.24: Olezarsen for Hypertriglyceridemia and ASCVD

Brian Bergmark,

Watch time: 3m 40s
ACC.24: The LIBerate-CVD Trial

Evan A Stein,

Watch time: 7m 18s

Dirk Sibbing , Michael J Blaha , Rajinder Chawla , et al

Read time: 18m 10s

Gabriel Torres-Ruiz , Nuria Mallofré-Vila , Paola Rojas-Flores , et al

Read time: 18m
AHA 23: Preventive Cardiology in 2023

Michael Honigberg,

Watch time: 7m 3s
AHA 23: The ORFAN Study

Charalambos Antoniades,

Watch time: 10m
TCT 23: IFR SWEDEHEART

Matthias Gotberg,

Watch time: 7m 14s

Mohanad Gabani , Michael D Shapiro , Peter P Toth ,

Read time: 18m

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)

John F Beltrame , Peter Ong , Filippo Crea ,

Read time: 18m
ESC 23: LIBerate-HeFH Study

Frederick Raal,

Watch time: 4m 16s

Sivabaskari Pasupathy , Rosanna Tavella , Simon McRae , et al

Hans-Willi Breuer ,

Remo Albiero ,

Astrid Hubert , Andreas Seitz , Valeria Martínez Pereyra , et al

Kevin Cheng , Paul Sainsbury , Michael Fisher , et al

Yukiko Isekame , Sabiha Gati , Jose Antonio Aragon-Martin , et al

Ewa Dembowski , Michael H Davidson ,

Sumanth Khadke , Jovana Vidovic , Vinod Patel ,

Alberto Lorenzatti , Peter P Toth ,

Kausik Ray, , , et al

Watch time: 1h 35m (4 videos)

Kerry Layne , Albert Ferro ,

Julia Sikorska , James Uprichard ,

Media

AHA 23: Preventive Cardiology in 2023

Michael Honigberg,

Watch time: 7m 3s

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)
ESC 23 Late-Breaker Discussion: The RECORD MI Registry

Harriette Van Spall, Javed Butler,

Watch time: 9m 37s
ESC 23: The ILUMIEN IV Trial

Ziad A Ali,

Watch time: 4m 12s

Yugo Yamashita,

Joost Daemen, Allen Jeremias, Ziad A Ali, et al

Watch time: 55m 46s (1 video)
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s
Radcliffe & CardioNerds @AHA22: Reduction of Lp(a) With Small Interfering RNA

Gurleen Kaur, Michelle O'Donoghue,

Watch time: 14m 28s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur,

Watch time: 14m 20s
ESC 22: ALL-HEART: Allopurionol in the Treatment of Ischaemic Heart Disease

Isla Mackenzie,

Watch time: 2m 29s

Media

ACC.24: The LIBerate-CVD Trial

Evan A Stein,

Watch time: 7m 18s
ACC.24: Olezarsen for Hypertriglyceridemia and ASCVD

Brian Bergmark,

Watch time: 3m 40s
ACC.24: The ORBITA COSMIC Trial

Rasha Al-Lamee, Michael Foley,

Watch time: 4m 45s
CRT 23: PCI Vs CABG in Left Main CAD With or Without Diabetes: A Pooled Ana

Prakriti Gaba,

Watch time: 4m 19s
ESC 2019 - Changes to ESC Guidelines for High-Risk Pulmonary Embolism Patients

Nicolas Meneveau,

Watch time: 1m 19s

Joost Daemen, Allen Jeremias, Ziad A Ali, et al

Watch time: 55m 46s (1 video)
View From The Thoraxcenter: What's Hot at ESC 2020

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 15m 53s
ESC 2020: APOC-III Reduction in Cardiovascular Disease

Jean-Claude Tardif,

Watch time: 8m 45s

Yassir Javaid, , , et al

Watch time: 18m 47s (4 videos)
ACC 23: MK-0616: Oral PCSK9 inhibitor In Hypercholesterolemia Patients

Christie Ballantyne,

Watch time: 3m 44s

Yugo Yamashita,

ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s

Articles

The ISCHEMIA Trial: What is the Message for the Interventionalist?

Emmanuel Ako

,

Sukhjinder Nijjer

,

Abtehale Al-Hussaini

,

Raffi Kaprielian

,

Published:

01 June 2021

Citation:

European Cardiology Review 2021;16:e24.

DOI:

https://doi.org/10.15420/ecr.2020.37
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 5782
  • Downloads: Downloads 322
  • Citations: 1

Trial Update: FORECAST, COMBINE OCT-FFR and DEFINE-PCI

Kevin Cheng

,

Ranil de Silva

,

Published:

21 May 2021

Citation:

European Cardiology Review 2021;16:e22.

DOI:

https://doi.org/10.15420/ecr.2021.07
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 948
  • Downloads: Downloads 50

Inflammation and Cardiovascular Disease: The Future

Natalie Arnold

,

Katharina Lechner

,

Christoph Waldeyer

,

Michael D Shapiro

,

Wolfgang Koenig

,

Published:

17 May 2021

Citation:

European Cardiology Review 2021;16:e20.

DOI:

https://doi.org/10.15420/ecr.2020.50
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 3418
  • Downloads: Downloads 237
  • Citations: 50

The Association Between Psoriasis and Cardiovascular Diseases

Ahmed Zwain

,

Mohanad Aldiwani

,

Hussein Taqi

,

Published:

13 May 2021

Citation:

European Cardiology Review 2021;16:e19.

DOI:

https://doi.org/10.15420/ecr.2020.15.R2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 2454
  • Downloads: Downloads 75
  • Citations: 9